|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 975 F Street NW Suite 500 |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 40032282-51
|
||||||||
|
6. House ID# 399140000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Richard J Tarplin, Manager |
Date | 04/21/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research.
Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare
and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research.
Affordable Care Act (ACA) - repeal of Section 9003, FSA/HSA over-the-counter prescription requirement
Quality Measure Development
Electronic Health Records - Meaningful Use Regulations
In-Office Ancillary Services Exception
Prescription Drug Diversion and Abuse
Prescriber Education and CME Training
PL 112-144 - The Food and Drug Administration Safety and Innovation Act - effect of implementation on drug shortage issues.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Tarplin |
|
Assistant Secretary for Legislation/HHS; Principal |
|
continued |
Tarplin |
|
Deputy Assistant Secretary for Legislation/HHS; |
|
continued |
Tarplin |
|
Staff Director, Senate Subcommittee on Children |
|
continued |
Tarplin |
|
and Families |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Public Law 111-5, the American Recovery and Reinvestment Act of 2009 - Implementation issues related to Medicare incentives and penalties for adoption of health information technology, comparative effectiveness issues.
Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid physician payments, comparative effectiveness research, quality reporting and improvement initiatives.
Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid physician payments.
Public Law 111-192 (H.R. 3962), the Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 - Medicare physician payment issues.
P.L. 112-096, the Middle Class Tax Relief and Job Creation Act of 2012 - issues related to Medicare and Medicaid physician payments.
P.L. 112-240, the American Taxpayer Relief Act of 2012 - Medicare physician payment issues.
S. 388, American Family Economic Protection Act of 2013 - sequestration issues affecting Medicare physician payments and drug reimbursement issues.
H.R. 1310, Medicare Patient Empowerment Act of 2013, all provisions
S. 236, Medicare Patient Empowerment Act, all provisions
H.R. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 351, Protecting Seniors' Access to Medicare Act of 2013, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
The Medicare Payment Stability and Premium Security Act ( Draft bill)
Medicare Program - Long term reform proposals for the Medicare physician payment system.
Medicare Program - Regulatory and administrative issues with the Medicare physician formula.
Medicare Program - Shared Savings/Accountable Care Organizations
Medicare program - Value-based modifier
Medicare program - Quality Reporting Programs
Medicare program - New payment models/measuring quality performance
Medicare and Medicaid programs - Tavenner CMS nomination
Medicaid program - Primary care bonus
Discussions concerning potential debt limit extension and deficit reduction legislation - physician payment issues.
Public Law No: 113-46, Continuing Appropriations Act , 2014 - Medicare and Medicaid savings issues.
P.L 113-67, Continuing Appropriations Resolution for 2014 - Medicare physician payments
S.2000 - The SGR Repeal and Medicare Provider Payment Modernization Act of 2014
H.R.4015 -The SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Public Law 113-93 - The Protecting Access to Medicare Act of 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Tarplin |
|
Assistant Secretary for Legislation/HHS; Principal |
|
continued |
Tarplin |
|
Deputy Assistant Secretary for Legislation/HHS; |
|
continued |
Tarplin |
|
Staff Director, Senate Subcommittee on Children |
|
continued |
Tarplin |
|
and Families. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - implementation issues related to reauthorization of user fees for prescription drug, medical device, and biologics approval - Regulation of online pharmacies and prescription painkillers.
Prescriber Education and CME Training
H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 - drug shortage issues.
S. 959 - Pharmaceutical Compounding Quality and Accountability Act - drug shortage issues, prescriber education and CME training.
H.R. 2186 - Valid Compounding Act - drug shortage issues
H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013- drug shortage issues
H.R. 3089 - the Compounding Clarity Act - drug shortage issues.
Public Law 113-54 - the Drug Quality and Security Act - drug shortage issues.
FDA and HHS recommendations for rescheduling certain drugs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Tarplin |
|
Assistant Secretary for Legislation/HHS; Principal |
|
continued |
Tarplin |
|
Deputy Assistant Secretary for Legislation/HHS; |
|
continued |
Tarplin |
|
Staff Director, Senate Subcommittee on Children |
|
continued |
Tarplin |
|
and Families. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |